The Current State of FLT3 Inhibition in Acute Myeloid Leukemia - Pitfalls and Promises.

Abstract

Katherine A Minson1,2, Deborah DeRyckere1 and Douglas K Graham1* 1Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta and Emory University, USA 2Department of Pediatrics, Atlanta, GA, USA *Corresponding author: Douglas K Graham, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta and Emory University, Department of Pediatrics, Atlanta, GA, USA, Tel: (404) 727-5002; Fax: (404) 727-4455; E-mail: Douglas.Graham@choa.org